• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

坏死性小肠结肠炎患儿血清代谢组学与粪便微生物组的综合分析

Integrated analysis of serum metabolomics and fecal microbiome in infants with necrotizing enterocolitis.

作者信息

Lin Zhi-Ying, He Shan-Shan, Mo Zi-Tong, Liao Xiao-Tian, Feng Zhou-Shan, Kong Juan, Zhu Lu, Li Ying, Tan Hui-Yuan, Su Zhi-Wen, Jia Chun-Hong, Wu Fan

机构信息

Guangzhou Key Laboratory of Neonatal Intestinal Diseases, Department of Neonatology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

Department of Obstetrics and Gynecology, The Third Affiliated Hospital, Guangzhou Medical University, Guangzhou, China.

出版信息

Front Microbiol. 2025 Jun 5;16:1584041. doi: 10.3389/fmicb.2025.1584041. eCollection 2025.

DOI:10.3389/fmicb.2025.1584041
PMID:40539103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12176818/
Abstract

BACKGROUND

Necrotizing enterocolitis (NEC), a lethal gastrointestinal disorder in preterm infants, remains poorly understood in its pathology, and early diagnosis are critically limited. Multi-omics approaches present unprecedented opportunities to elucidate NEC pathogenesis and identify clinically translatable biomarkers.

METHODS

Infants with Bell stage II-III NEC and gestational age-matched controls were enrolled. Serum/stool samples from NEC patients at acute (NEC-D) and recovery (NEC-R) phases, and controls (non-NEC) were collected. Fecal metagenomic sequencing and serum untargeted metabolomic profiling were performed. Clinical parameters were compared.

RESULTS

The study comprised seven NEC and seven non-NEC infants. Baseline neonatal characteristics and maternal perinatal parameters showed no significant differences between NEC-D and non-NEC except for markedly lower leukocyte counts in NEC infants. Fecal metagenomics revealed severely diminished alpha diversity in NEC-D versus both non-NEC controls and NEC-R, characterized with lower Chao1 index. NEC-D exhibited elevated relative abundance alongside reduced , , , and . Correspondingly, KEGG functional gene analysis demonstrated impaired metabolism in NEC-D. Serum metabolomics identified significantly decreased ornithine, DL-arginine, L-threonine, leucine, and D-proline in NEC-D versus non-NEC. NEC-D also showed lower taurodeoxycholic acid, glycocholic acid, and chenodeoxycholic acid compared to NEC-R. Integrative analysis revealed a positive correlation between the metabolites D-proline and ornithine and the , , and abundance.

CONCLUSION

NEC is characterized by gut microbiota dysbiosis with reduced diversity, altered functional gene expression, and disrupted host-microbiota metabolic crosstalk. The identified serum metabolite-microbiome correlations provide mechanistic insights into NEC pathogenesis and potential diagnostic biomarkers.

摘要

背景

坏死性小肠结肠炎(NEC)是一种发生于早产儿的致命性胃肠道疾病,其病理机制仍未完全明确,早期诊断也受到严重限制。多组学方法为阐明NEC发病机制和识别具有临床转化价值的生物标志物提供了前所未有的机遇。

方法

纳入Bell II-III期NEC婴儿及孕周匹配的对照婴儿。收集NEC患者急性期(NEC-D)和恢复期(NEC-R)以及对照(非NEC)的血清/粪便样本。进行粪便宏基因组测序和血清非靶向代谢组学分析。比较临床参数。

结果

该研究纳入7例NEC婴儿和7例非NEC婴儿。除NEC婴儿白细胞计数明显较低外,NEC-D组与非NEC组的基线新生儿特征和母亲围产期参数无显著差异。粪便宏基因组学显示,与非NEC对照和NEC-R相比,NEC-D的α多样性严重降低,特征为Chao1指数较低。NEC-D显示 、 、 、 相对丰度升高而 降低。相应地,KEGG功能基因分析表明NEC-D存在代谢受损。血清代谢组学分析发现,与非NEC相比,NEC-D中鸟氨酸、DL-精氨酸L-苏氨酸、亮氨酸和D-脯氨酸显著降低。与NEC-R相比,NEC-D的牛磺去氧胆酸、甘氨胆酸和鹅去氧胆酸也较低。综合分析显示,代谢物D-脯氨酸和鸟氨酸与 、 、 丰度之间呈正相关。

结论

NEC的特征是肠道微生物群失调,表现为多样性降低、功能基因表达改变以及宿主-微生物群代谢串扰破坏。所确定的血清代谢物-微生物组相关性为NEC发病机制和潜在诊断生物标志物提供了机制性见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12176818/1b119d97ba62/fmicb-16-1584041-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12176818/84815b8825b0/fmicb-16-1584041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12176818/9a420c07bbc1/fmicb-16-1584041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12176818/0c1376dede0d/fmicb-16-1584041-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12176818/1b119d97ba62/fmicb-16-1584041-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12176818/84815b8825b0/fmicb-16-1584041-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12176818/9a420c07bbc1/fmicb-16-1584041-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12176818/0c1376dede0d/fmicb-16-1584041-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/52e8/12176818/1b119d97ba62/fmicb-16-1584041-g004.jpg

相似文献

1
Integrated analysis of serum metabolomics and fecal microbiome in infants with necrotizing enterocolitis.坏死性小肠结肠炎患儿血清代谢组学与粪便微生物组的综合分析
Front Microbiol. 2025 Jun 5;16:1584041. doi: 10.3389/fmicb.2025.1584041. eCollection 2025.
2
The Metabolome and the Gut Microbiota for the Prediction of Necrotizing Enterocolitis and Spontaneous Intestinal Perforation: A Systematic Review.代谢组学和肠道微生物组预测坏死性小肠结肠炎和自发性肠穿孔:系统评价。
Nutrients. 2022 Sep 18;14(18):3859. doi: 10.3390/nu14183859.
3
Intestinal dysbiosis in preterm infants preceding necrotizing enterocolitis: a systematic review and meta-analysis.早产儿坏死性小肠结肠炎发病前肠道菌群失调:系统评价和荟萃分析。
Microbiome. 2017 Mar 9;5(1):31. doi: 10.1186/s40168-017-0248-8.
4
Arginine supplementation for prevention of necrotising enterocolitis in preterm infants.补充精氨酸预防早产儿坏死性小肠结肠炎
Cochrane Database Syst Rev. 2017 Apr 11;4(4):CD004339. doi: 10.1002/14651858.CD004339.pub4.
5
Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants.布洛芬用于治疗早产和/或低出生体重婴儿的动脉导管未闭。
Cochrane Database Syst Rev. 2008 Jan 23(1):CD003481. doi: 10.1002/14651858.CD003481.pub3.
6
Integrating Gut Microbiome and Metabolomics with Magnetic Resonance Enterography to Advance Bowel Damage Prediction in Crohn's Disease.整合肠道微生物组和代谢组学与磁共振肠造影术以推进克罗恩病肠道损伤预测
J Inflamm Res. 2025 Jun 11;18:7631-7649. doi: 10.2147/JIR.S524671. eCollection 2025.
7
Probiotics for prevention of necrotizing enterocolitis in preterm infants.益生菌预防早产儿坏死性小肠结肠炎
Cochrane Database Syst Rev. 2008 Jan 23(1):CD005496. doi: 10.1002/14651858.CD005496.pub2.
8
Distinct microbiota profiles in non-survivors in preterm infants with surgical necrotizing enterocolitis: Insights from FFPE intestinal tissue analysis.患有外科坏死性小肠结肠炎的早产儿非幸存者的不同微生物群特征:来自福尔马林固定石蜡包埋肠道组织分析的见解
J Neonatal Perinatal Med. 2025 Jun 24:19345798251353777. doi: 10.1177/19345798251353777.
9
Trophic feedings for parenterally fed infants.经肠道营养在肠外营养婴儿中的应用。
Cochrane Database Syst Rev. 2005 Jul 20(3):CD000504. doi: 10.1002/14651858.CD000504.pub2.
10
Arginine supplementation for prevention of necrotising enterocolitis in preterm infants.补充精氨酸预防早产儿坏死性小肠结肠炎
Cochrane Database Syst Rev. 2007 Jul 18(3):CD004339. doi: 10.1002/14651858.CD004339.pub3.

本文引用的文献

1
Digging deeper into necrotizing enterocolitis: bridging clinical, microbial, and molecular perspectives.深入探究坏死性小肠结肠炎:连接临床、微生物和分子层面的观点
Gut Microbes. 2025 Dec;17(1):2451071. doi: 10.1080/19490976.2025.2451071. Epub 2025 Jan 18.
2
Human milk microbiota, oligosaccharide profiles, and infant gut microbiome in preterm infants diagnosed with necrotizing enterocolitis.患坏死性小肠结肠炎的早产儿的人乳微生物群、低聚糖谱和婴儿肠道微生物组。
Cell Rep Med. 2024 Sep 17;5(9):101708. doi: 10.1016/j.xcrm.2024.101708. Epub 2024 Aug 30.
3
Epigenetic Insights Into Necrotizing Enterocolitis: Unraveling Methylation-Regulated Biomarkers.
坏死性小肠结肠炎的表观遗传学见解:揭示甲基化调控的生物标志物
Inflammation. 2025 Feb;48(1):236-253. doi: 10.1007/s10753-024-02054-x. Epub 2024 May 30.
4
Gut microbe-derived milnacipran enhances tolerance to gut ischemia/reperfusion injury.肠道微生物衍生的米那普仑增强了对肠道缺血/再灌注损伤的耐受性。
Cell Rep Med. 2023 Mar 21;4(3):100979. doi: 10.1016/j.xcrm.2023.100979.
5
Biomarkers of necrotizing enterocolitis in the era of machine learning and omics.基于机器学习和组学的坏死性小肠结肠炎生物标志物。
Semin Perinatol. 2023 Feb;47(1):151693. doi: 10.1016/j.semperi.2022.151693. Epub 2022 Dec 21.
6
A Prospective, Case-Control Study of Serum Metabolomics in Neonates with Late-Onset Sepsis and Necrotizing Enterocolitis.一项关于晚发性败血症和坏死性小肠结肠炎新生儿血清代谢组学的前瞻性病例对照研究。
J Clin Med. 2022 Sep 7;11(18):5270. doi: 10.3390/jcm11185270.
7
Methionine metabolism controls the B cell EBV epigenome and viral latency.蛋氨酸代谢控制 B 细胞 EBV 表观基因组和病毒潜伏期。
Cell Metab. 2022 Sep 6;34(9):1280-1297.e9. doi: 10.1016/j.cmet.2022.08.008.
8
Spatially resolved multi-omics deciphers bidirectional tumor-host interdependence in glioblastoma.空间分辨多组学解析胶质母细胞瘤中肿瘤-宿主的双向相互依赖关系。
Cancer Cell. 2022 Jun 13;40(6):639-655.e13. doi: 10.1016/j.ccell.2022.05.009.
9
Unraveling the Microbiome of Necrotizing Enterocolitis: Insights in Novel Microbial and Metabolomic Biomarkers.解析坏死性小肠结肠炎的微生物组学:新型微生物和代谢组学生物标志物的研究进展。
Microbiol Spectr. 2021 Oct 31;9(2):e0117621. doi: 10.1128/Spectrum.01176-21. Epub 2021 Oct 27.
10
Clinical Insights into Mitochondrial Neurodevelopmental and Neurodegenerative Disorders: Their Biosignatures from Mass Spectrometry-Based Metabolomics.线粒体神经发育和神经退行性疾病的临床见解:基于质谱代谢组学的生物标志物
Metabolites. 2021 Apr 10;11(4):233. doi: 10.3390/metabo11040233.